Company History
Our Journey so Far
-
September 2013
Alderley Analytical is born from a tiny atom of an idea between our 4 founding scientists.
-
February 2014
We move into laboratory space at Alderley Park, Cheshire and purchase our first Mass Spectrometer machine (Waters Xevo TQ-S Triple Quad).
-
Summer 2014
Between June and September, we win our first non-regulatory, and then regulatory, contracts.
-
September 2014
Following our first inspection, we’re delighted to achieve our Good Laboratory Practice (GLP) accreditation.
-
November 2014
We’re very proud to win the ‘Start-up of the year’ award at the North East Cheshire Business Awards.
-
July 2015
We receive £300K equity investment from Alderley Park Ventures and The North West Fund for Biomedical.
-
August 2016
In a significant new business win, the company is chosen as the Preferred Provider for Bioanalysis to a mid-sized biotech company in the Nordic region.
-
October 2016
Our 3rd mass spectrometer arrives.
-
November 2016
We receive a second injection of £300K funding from angel investors and the directors enjoy being able to sleep soundly again.
-
March 2017
The business becomes profitable.
-
April 2017
Our 18th employee joins us as our growth continues.
-
May 2017
Our 4th Mass Spectrometer arrives.
-
June 2017
Our continued success and the ever-growing team means we have to move to even bigger premises at Alderley Park and purchase yet another mass spectrometer.
-
September 2017
A successful MHRA GLP inspection.
-
October 2017
We thought we needed a facelift, so our new brand is officially launched!
-
June 2018
Our 5th LC-MS/MS is installed.
-
September 2018
6th Mass Spectrometer installed.
-
December 2018
Another successful MHRA inspection.
-
November 2019
Mass spec Number 7 installed and validated.
-
Feb 2020
COVID hits, we change our safety policies and make the business COVID safe, we continue to work through the pandemic supporting our clients with their continuing needs.
-
September 2020
A successful remote MHRA inspection.
-
January 2021
Further investment into Ligand Binding Technology with the purchase of our first Meso Scale Discovery (MSD) instrument.
-
March 2021
WATSON LIMS purchased.
-
October 2021
Our regulatory support for Anti-drug Antibodies (ADA) Assays begins.
-
December 2021
WATSON LIMS successfully validated for use.